Kumagaya-shi

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• High blood pressure2 trials
• Atrial fibrillation1 trial
• Idiopathic pulmonary fibrosis1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• AstraZeneca5 trials

Running trials

• Recruiting

  A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  NCT07624305· Phase 3· AstraZeneca· Source

  Contact: AstraZeneca Clinical AstraZeneca Clinical

• Recruiting

  A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  NCT07652658· Phase 2· AstraZeneca· Source

• Recruiting

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

  NCT06268873· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• High blood pressure1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting

Closed trials

• Terminated

  Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

  NCT04847232· Phase 3· AstraZeneca· Source